Infliximab Biosimilar Maintains Inflammation Control in Non-

Biosimilar infliximab-dyyb proves successful in achieving and maintaining the control of non-infectious uveitis in the study cohort.

Related Keywords

Debraa Goldstein , , Uveitis Service , Northwestern University Debraa Goldstein , Feinberg School Of Medicine , Drug Administration , Northwestern University , Feinberg School ,